Area 1 (‘Economy’): Improve the productivity, resilience and competitiveness of European Animal Production
Development of new serological or molecular diagnostic assays. Production of recombinant proteins or monoclonal antibodies.
INGENASA is a SME Biotechnology company dedicated to the research, development and marketing of products designed for the diagnosis and prevention of infectious diseases, especially those affecting the Animal Health sector. The company, with base in Madrid, has 46 employees and has thirty years’ experience in the production of recombinant proteins and monoclonal antibodies (Mabs).
INGENASA has developed a variety of systems, currently commercialized, for serological diagnosis based on Mabs and recombinant proteins (ELISAs and Lateral Flow Devices), and molecular diagnosis (PCR, RT-PCR and real time PCR) of many animal diseases, especially those causing important economic losses in livestock animals and pets. Moreover, INGENASA is working on the development of protein microarray assays.
The company has wide experience in going from lab prototypes to final commercial products in this market.
INGENASA has extensive experience in the participation, co-ordination and management of National and European research programs.